123531-52-2

Usage

Uses

Used in Pharmaceutical Development:
Ethyl Imidazo[1,2-a]pyridine-3-carboxylate is used as a potential pharmaceutical agent for its potential to inhibit enzymes involved in cellular processes. Its structure and properties make it a promising candidate for the development of new drugs targeting specific biological pathways.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, Ethyl Imidazo[1,2-a]pyridine-3-carboxylate serves as a valuable compound for studying the structure-activity relationships of imidazo[1,2-a]pyridine derivatives. This research aids in understanding how modifications to the compound's structure can influence its biological activity and therapeutic potential.
Used in Drug Development:
Ethyl Imidazo[1,2-a]pyridine-3-carboxylate is utilized in drug development to explore its potential as an enzyme inhibitor, which could lead to the creation of new therapeutic agents for various diseases and conditions. Its role in inhibiting specific enzymes may offer targeted treatments with fewer side effects compared to broader-spectrum drugs.
Used in Biological Activity Studies:
Ethyl Imidazo[1,2-a]pyridine-3-carboxylate is also used in biological activity studies to investigate its effects on various biological processes. Understanding how Ethyl Imidazo[1,2-a]pyridine-3-carboxylate interacts with biological systems can provide insights into its potential applications and mechanisms of action in medicine.

InChI:InChI=1/C10H10N2O2/c1-2-14-10(13)8-7-11-9-5-3-4-6-12(8)9/h3-7H,2H2,1H3

Upstream product

• 504-29-0 2-aminopyridine 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 105-36-2 ethyl bromoacetate 
• 57040-75-2 N,N-dimethyl-N'-pyridin-2-yl-formamidine 
• 609-15-4 ethyl 2-chloro-3-oxo-butyrate 

Downstream Products

• 1367714-24-6 C₂₀H₂₀F₂N₄O 
• 6200-60-8 imidazo[1,2-a]pyridine-3-carboxylic acid 
• 115854-31-4 N-Benzyl-6-imidazo[1,2-a]pyridin-3-yl-[1,3,5]triazine-2,4-diamine 
• 115854-32-5 6-Imidazo[1,2-a]pyridin-3-yl-N-(2-phenoxy-ethyl)-[1,3,5]triazine-2,4-diamine 

Relevant academic research and scientific papers

Discovery of potent colony-stimulating factor 1 receptor inhibitors by replacement of hinge-binder moieties

Tumor-associated macrophages (TAMs) are predominantly associated with tumor growth. Colony-stimulating factor 1 receptor (CSF1R) acts as a key regulator of TAM survival and differentiation and is a molecular target for cancer therapies. Herein, novel CSF1

Convenient two-step one-pot synthesis of 3-substituted imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines

Abstract: A convenient and novel two-step one-pot method for the synthesis of 3-substituted imidazo[1,2-a]pyridines and 3-substituted imidazo[1,2-b]pyridazines was developed through the reaction of heterocyclic amines and N,?N-dimethylformamide dimethyl a

IMIDAZO-CONDENSED BICYCLES AS INHIBITORS OF DISCOIDIN DOMAIN RECEPTORS (DDRS)

The invention provides a compound of formula (I) (Formula (I)) or a tautomeric form, stereochemically isomeric form, N-oxide, pharmaceutically acceptable salt or solvate thereof, wherein R2, R3, R4, Ra, Rb

Identification of fused bicyclic heterocycles as potent and selective 5-HT2A receptor antagonists for the treatment of insomnia

A series of fused bicyclic heterocycles was identified as potent and selective 5-HT2A receptor antagonists. Optimization of the series resulted in compounds that had improved PK properties, favorable CNS partitioning, good pharmacokinetic properties, and significant improvements on deep sleep (delta power) and sleep consolidation.